StockNews.com Initiates Coverage on bluebird bio (NASDAQ:BLUE)
Research analysts at StockNews.com began coverage on shares of bluebird bio (NASDAQ:BLUE – Get Free Report) in a note issued to investors on Wednesday. The brokerage set a “sell” rating on the biotechnology company’s stock. BLUE has been the subject of several other research reports. Bank of America downgraded shares of bluebird bio from a […]
Research analysts at StockNews.com began coverage on shares of bluebird bio (NASDAQ:BLUE – Get Free Report) in a note issued to investors on Wednesday. The brokerage set a “sell” rating on the biotechnology company’s stock. BLUE has been the subject of several other research reports. Bank of America downgraded shares of bluebird bio from a […]
